Brokerages Set NeoGenomics, Inc. (NASDAQ:NEO) PT at $19.60
NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) has been given an average rating of “Moderate Buy” by the ten brokerages that are currently covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 12-month price target among […]
NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) has been given an average rating of “Moderate Buy” by the ten brokerages that are currently covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 12-month price target among […]
